http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE40002-E

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a515621118514c16b9403f0c05713fba
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00865
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-008
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-01
filingDate 2003-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49ebb5714ad6ac6b7ba365bc4af5200e
publicationDate 2008-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-RE40002-E
titleOfInvention Treatment of presbyopia and other eye disorders using a scanning laser system
abstract Presbyopia is treated by a method which uses ablative lasers to ablate the sclera tissue and increase the accommodation of the ciliary body. Tissue bleeding is prevented by an ablative laser having a wavelength of between 0.15 and 3.2 micron. A scanning system is proposed to perform various patterns on the sclera area of the cornea to treat presbyopia and to prevent other eye disorder such as glaucoma. Laser parameters are determined for accurate sclera expansion. n REEXAMINATION RESULTS n The questions raised in reexamination request no. 90/006,090, filed Aug. 22, 2001, have been considered and the results thereof are reflected in this reissue patent which constitutes the reexamination certificate required by 35 U.S.C. 307 as provided in 37 CFR 1.570(e), for ex parte reexaminations, or the reexamination certificate required by 35 U.S.C. 316 as provided in 37 CFR 1.997(e) for inter partes reexaminations.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463541-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545338-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8617146-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007173795-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010022995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9375349-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114145908-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D694890-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D695408-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8480659-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8382745-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011022036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011022035-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011160710-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010114079-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8801186-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010042079-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8465478-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8708491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010292678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8556425-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9180051-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE46493-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8500723-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011190740-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007055220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842675-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007185475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011166557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8758332-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8262646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007173794-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010004643-A1
priorityDate 1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5549598-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5163934-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6210401-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6099522-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5533997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4773414-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5152760-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5354331-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6258082-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5484432-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5599341-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6090102-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5490849-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5782822-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6161546-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5630810-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197018-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5928129-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6203538-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197056-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5722952-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6263879-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9841177-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4592065-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6090100-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003220630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001029363-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5529076-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5465737-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544408

Total number of triples: 83.